Asserter profile

ELLODI PHARMACEUTICALS, L.P.

operating company1 patents now1 ever0 cases filed during tenure1 connections

PTAB exposure

1of this entity’s patents have been challenged at PTAB (1 total proceeding). 1 currently have active proceedings.

Two-hop network

Edges marked ⚖️ overlap with at least one infringement suit filed during the receiving entity’s tenure with the patent. Bold-bordered = this entity. Red = NPE; orange = shell LLC; green = defensive aggregator; blue = operating company.

flowchart LR
    Nellodi_pharmaceuticals["ELLODI PHARMACEUTICALS, L.P."]
    Nadare_pharmaceuticals_us["ADARE PHARMACEUTICALS US, LP"]
    Nadare_development_i["ADARE DEVELOPMENT, I L.P."]
    Nadare_pharmaceuticals_us -->|"2022 · Change of Name · 12290598"| Nellodi_pharmaceuticals
    Nadare_development_i -->|"2022 · Change of Name · 12290598"| Nadare_pharmaceuticals_us
    classDef focal fill:#fef3c7,stroke:#92400e,stroke-width:3px,color:#1c1917
    classDef npe fill:#fee2e2,stroke:#be123c,stroke-width:2px,color:#1c1917
    classDef shell fill:#fed7aa,stroke:#9a3412,stroke-width:2px,color:#1c1917
    classDef defensive fill:#dcfce7,stroke:#15803d,stroke-width:2px,color:#1c1917
    classDef operating fill:#e0f2fe,stroke:#075985,stroke-width:1px,color:#1c1917
    class Nellodi_pharmaceuticals focal
    class Nadare_pharmaceuticals_us operating
    class Nadare_development_i operating

Patents currently held (1)

Connected entities (1)

Correspondent attorneys (1)

Attorneys / firms recorded with USPTO when this entity received a patent. Recurrence is the signal — many firms do both NPE and operating-company patent work, so a single appearance doesn’t mean much.

  • (no name)· STERNE KESSLER GOLDSTEIN & FOX1 appearance